Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea

Clinical trial NCT02090673 · COMPLETED

Trial details

NCT number: NCT02090673
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus Type 2

Start date: 2009-02-01
Primary completion: 2014-03-01
Enrollment: 1711

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.